IN THE NEWS: Dr. Zonder on the management of bispecific antibody-associated toxicities in multiple myeloma


Jeffrey Zonder, M.D., hematologist, medical oncologist, leader of the Multiple Myeloma and Amyloidosis Multidisciplinary Team (MDT) and member of the Hematology Oncology MDT at Karmanos, talks to OncLive TV about managing toxicities associated with bispecific antibodies in multiple myeloma patients.

Watch here.